Search Results

not curable, increasingly more patients are living with MM for longer periods as survival improves. The focus has centered on maximizing quality of life for patients with MM. Improvements in supportive care will allow patients to gain the benefit of

optimal supportive care strategies for these particularly impactful quality-of-life issues in patients with HNC. Epidemiology Potential primary sites of HNC include the oral cavity, pharynx, larynx, nasal cavity, and paranasal sinuses. In 2019, more

where future interventions could be applied to improve the integration of palliative care for patients with HM, current practices first need to be identified. Therefore, we aimed to describe healthcare utilization, supportive care, and interventions at

“Genetic variability is very challenging, and we have to work harder to try and identify what underlies responses [to interventions for cancer-induced pain],” commented David S. Craig, PharmD, Pharmacist Lead–Acute Pain/Supportive Care Medicine

supportive care setting, it is not surprising that patient and family inquiries about purported cannabinoid benefits for common cancer-related symptoms, such as pain, nausea, and poor appetite, have become more frequent as medical marijuana programs have

the practical aspects of dose delivery to a patient, successful outcome of patient treatments, and convenience to the staff delivering the treatment. Supportive Care All professionals caring for patients with H&N cancer should assess supportive

dietitians is limited. Although exercise training can be beneficial during and after treatment, intervention during chemotherapy may be especially important as supportive care in managing treatment-related side effects. With respect to exercise during

. These results support the favorable clinical and patient-reported outcomes observed with CEMI- versus CHEMO-treated pts in EMPOWER-Lung 1. CLO22-050 Table. Supportive Care Medication utilization in EMPOWER-Lung 1 CEMI, cemiplimab; CHEMO

clinically tested with parents of AYAs with hematologic malignancies between 2009 and 2011 within the outpatient supportive care clinic at the University Hospital of Magdeburg. 28 , 31 The 5 sessions were offered once weekly. One treating psychotherapist was

resection (± adjuvant chemotherapy), (3) a resection without neoadjuvant treatment, (4) definitive chemoradiotherapy (dCRT; ie, chemotherapy and concurrent long-term radiotherapy without a resection), (5) palliative chemotherapy, and (6) best supportive care